Anandamide transport: A critical review

Life Sciences

Volumn 77, Issue 14, 2005, Pages 1584-1604

  Glaser, Sherrye T ^a   Kaczocha, Martin ^b   Deutsch, Dale G ^b  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Anandamide; BSA; Diffusion; FAAH; Transport; Uptake

Indexed keywords

ANANDAMIDE; BOVINE SERUM ALBUMIN; CANNABINOID RECEPTOR; ENZYME; FATTY ACID; FATTY ACID AMIDASE; LIPID BINDING PROTEIN; PLASTIC; PROTEIN; RECEPTOR BLOCKING AGENT;

ARTIFACT; ASSAY; BINDING AFFINITY; CELL; CELL MEMBRANE; CELL TRANSPORT; CELL TYPE; CONFERENCE PAPER; DIFFUSION; FATTY ACID TRANSPORT; HYDROPHOBICITY; IN VIVO STUDY; INCUBATION TIME; KINETICS; LABORATORY; METABOLISM; NONHUMAN; PROTEIN DOMAIN; PROTEIN INTERACTION; RECEPTOR BINDING; STEADY STATE; TRANSGENIC MOUSE; TRANSPORT KINETICS;

AMIDOHYDROLASES; ARACHIDONIC ACIDS; BENZAMIDES; BENZYL COMPOUNDS; BIOLOGICAL ASSAY; BIOLOGICAL TRANSPORT; CELL CULTURE TECHNIQUES; CELL MEMBRANE; FATTY ACID TRANSPORT PROTEINS; FURANS; KINETICS; POLYUNSATURATED ALKAMIDES; RECEPTORS, CANNABINOID; SERUM ALBUMIN, BOVINE;

BOVINAE; MUS MUSCULUS;

EID: 23044479980     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.05.007     Document Type: Conference Paper

References (57)

1. N.A. Abumrad, J.H. Park, and C.R. Park Permeation of long-chain fatty acid into adipocytes. Kinetics, specificity, and evidence for involvement of a membrane protein Journal of Biological Chemistry 259 14 1984 8945 8953
2. M. Bari, N. Battista, F. Fezza, A. Finazzi-Agro, and M. Maccarrone Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis Journal of Biological Chemistry 280 13 2005 12212 12220
3. B.S. Basavarajappa, M. Saito, T.B. Cooper, and B.L. Hungund Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons European Journal of Pharmacology 466 1-2 2003 73 83
4. M. Beltramo, N. Stella, A. Calignano, S.Y. Lin, A. Makriyannis, and D. Piomelli Functional role of high-affinity anandamide transport, as revealed by selective inhibition Science 277 5329 1997 1094 1097
5. T. Bisogno, S. Maurelli, D. Melck, L. De Petrocellis, and V. Di Marzo Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes Journal of Biological Chemistry 272 6 1997 3315 3323
6. T. Bisogno, D. Melck, L. De Petrocellis, M. Bobrov, N.M. Gretskaya, V.V. Bezuglov, N. Sitachitta, W.H. Gerwick, and V. Di Marzo Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase Biochemical and Biophysical Research Communications 248 3 1998 515 522
7. I.N. Bojesen, and H.S. Hansen Binding of anandamide to bovine serum albumin Journal of Lipid Research 44 9 2003 1790 1794
8. A. Bonen, J.J. Luiken, and J.F. Glatz Regulation of fatty acid transport and membrane transporters in health and disease Molecular and Cellular Biochemistry 239 1-2 2002 181 192
9. B.F. Cravatt, K. Demarest, M.P. Patricelli, M.H. Bracey, D.K. Giang, B.R. Martin, and A.H. Lichtman Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase Proceedings of the National Academy of Sciences of the United States of America 98 16 2001 9371 9376
10. T.A. Day, F. Rakhshan, D.G. Deutsch, and E.L. Barker Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide Molecular Pharmacology 59 6 2001 1369 1375
11. E. de Lago, J. Fernandez-Ruiz, S. Ortega-Gutierrez, A. Viso, M.L. Lopez-Rodriguez, and J.A. Ramos UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide European Journal of Pharmacology 449 1-2 2002 99 103
12. E. de Lago, A. Ligresti, G. Ortar, E. Morera, A. Cabranes, G. Pryce, M. Bifulco, D. Baker, J. Fernandez-Ruiz, and V. Di Marzo In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake European Journal of Pharmacology 484 2-3 2004 249 257
13. L. De Petrocellis, D. Melck, N. Ueda, S. Maurelli, Y. Kurahashi, S. Yamamoto, G. Marino, and V. Di Marzo Novel inhibitors of brain neuronal and basophilic anandamide amidohydrolase Biochemical and Biophysical Research Communications 231 1997 82 88
14. L. De Petrocellis, M.G. Cascio, and V. Di Marzo The endocannabinoid system: a general view and latest additions British Journal of Pharmacology 141 5 2004 765 774
15. D.G. Deutsch, and S.A. Chin Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist Biochemical Pharmacology 46 5 1993 791 796
16. D.G. Deutsch, R. Omeir, G. Arreaza, D. Salehani, G.D. Prestwich, Z. Huang, and A. Howlett Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase Biochemical Pharmacology 53 1997 255 260
17. D.G. Deutsch, S.T. Glaser, J.M. Howell, J.S. Kunz, R.A. Puffenbarger, C.J. Hillard, and N. Abumrad The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase Journal of Biological Chemistry 276 10 2001 6967 6973
18. D.G. Deutsch, N. Ueda, and S. Yamamoto The fatty acid amide hydrolase (FAAH) Prostaglandins, Leukotrienes and Essential Fatty Acids 66 2-3 2002 201 210
19. V. Di Marzo, A. Fontana, H. Cadas, S. Schinelli, G. Cimino, J.C. Schwartz, and D. Piomelli Formation and inactivation of endogenous cannabinoid anandamide in central neurons Nature 372 6507 1994 686 691
20. V. Di Marzo, C.S. Breivogel, Q. Tao, D.T. Bridgen, R.K. Razdan, A.M. Zimmer, A. Zimmer, and B.R. Martin Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain Journal of Neurochemistry 75 6 2000 2434 2444
21. L. Fasia, V. Karava, and A. Siafaka-Kapadai Uptake and metabolism of [3H]anandamide by rabbit platelets. Lack of transporter? European Journal of Biochemistry 270 17 2003 3498 3506
22. M. Febbraio, E. Guy, C. Coburn, F.F. Knapp Jr., A.L. Beets, N.A. Abumrad, and R.L. Silverstein The impact of overexpression and deficiency of fatty acid translocase (FAT)/CD36 Molecular and Cellular Biochemistry 239 1-2 2002 193 197
23. D. Fegley, S. Kathuria, R. Mercier, C. Li, A. Goutopoulos, A. Makriyannis, and D. Piomelli Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172 Proceedings of the National Academy of Sciences of the United States of America 101 23 2004 8756 8761
24. C.J. Fowler, and S.O. Jacobsson Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide-targets for drug development? Prostaglandins, Leukotrienes and Essential Fatty Acids 66 2-3 2002 193 200
25. C.J. Fowler, G. Tiger, A. Ligresti, M.L. Lopez-Rodriguez, and V. Di Marzo Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis-a difficult issue to handle European Journal of Pharmacology 492 1 2004 1 11
26. A. Giuffrida, F. Rodriguez de Fonseca, F. Nava, P. Loubet-Lescoulie, and D. Piomelli Elevated circulating levels of anandamide after administration of the transport inhibitor. AM404 European Journal of Pharmacology 408 2 2000 161 168
27. S.T. Glaser, N.A. Abumrad, F. Fatade, M. Kaczocha, K.M. Studholme, and D.G. Deutsch Evidence against the presence of an anandamide transporter Proceedings of the National Academy of Sciences of the United States of America 100 7 2003 4269 4274
28. J.A. Hamilton, W. Guo, and F. Kamp Mechanism of cellular uptake of long-chain fatty acids: do we need cellular proteins? Molecular and Cellular Biochemistry 239 1-2 2002 17 23
29. C.J. Hillard, and A. Jarrahian The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes Chemistry and Physics of Lipids 108 1-2 2000 123 134
30. C.J. Hillard, and A. Jarrahian Cellular accumulation of anandamide: consensus and controversy British Journal of Pharmacology 140 5 2003 802 808
31. C.J. Hillard, and A. Jarrahian Accumulation of anandamide: evidence for cellular diversity Neuropharmacology 48 8 2005 1072 1078
32. C.J. Hillard, W.S. Edgemond, A. Jarrahian, and W.B. Campbell Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion Journal of Neurochemistry 69 2 1997 631 638
33. A. Ibrahimi, and N.A. Abumrad Role of CD36 in membrane transport of long-chain fatty acids Current Opinion in Clinical Nutrition and Metabolic Care 5 2 2002 139 145
34. A. Jarrahian, S. Manna, W.S. Edgemond, W.B. Campbell, and C.J. Hillard Structure-activity relationships among N-arachidonylethanolamine (anandamide) head group analogues for the anandamide transporter Journal of Neurochemistry 74 6 2000 2597 2606
35. M. Karlsson, C. Pahlsson, and C.J. Fowler Reversible, temperature-dependent, and AM404-inhibitable adsorption of anandamide to cell culture wells as a confounding factor in release experiments European Journal of Pharmaceutical Sciences 22 2-3 2004 181 189
36. S. Kathuria, S. Gaetani, D. Fegley, F. Valino, A. Duranti, A. Tontini, M. Mor, G. Tarzia, G. La Rana, A. Calignano, A. Giustino, M. Tattoli, M. Palmery, V. Cuomo, and D. Piomelli Modulation of anxiety through blockade of anandamide hydrolysis Natural Medicine 9 1 2003 76 81
37. B.G. Kelley, and S.A. Thayer Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB(1) receptors European Journal of Pharmacology 496 1-3 2004 33 39
38. A.D. Khanolkar, V. Abadji, S. Lin, W.A. Hill, G. Taha, K. Abouzid, Z. Meng, P. Fan, and A. Makriyannis Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand Journal of Medicinal Chemistry 39 22 1996 4515 4519
39. A.M. Kleinfeld, S. Storms, and M. Watts Transport of long-chain native fatty acids across human erythrocyte ghost membranes Biochemistry 37 22 1998 8011 8019
40. A. Ligresti, E. Morera, M. Van Der Stelt, K. Monory, B. Lutz, G. Ortar, and V. Di Marzo Further evidence for the existence of a specific process for the membrane transport of anandamide Biochemical Journal 380 Pt. 1 2004 265 272
41. M.L. Lopez-Rodriguez, A. Viso, S. Ortega-Gutierrez, C.J. Fowler, G. Tiger, E. de Lago, J. Fernandez-Ruiz, and J.A. Ramos Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase Journal of Medicinal Chemistry 46 8 2003 1512 1522
42. M. Maccarrone, M. Bari, A. Menichelli, D. Del Principe, and A.F. Agro Anandamide activates human platelets through a pathway independent of the arachidonate cascade FEBS Letters 447 2-3 1999 277 282
43. B.R. Martin, D.R. Compton, B.F. Thomas, W.R. Prescott, P.J. Little, R.K. Razdan, M.R. Johnson, L.S. Melvin, R. Mechoulam, and S.J. Ward Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs Pharmacology, Biochemistry and Behavior 40 3 1991 471 478
44. B.R. Martin, I. Beletskaya, G. Patrick, R. Jefferson, R. Winckler, D.G. Deutsch, V. Di Marzo, O. Dasse, A. Mahadevan, and R.K. Razdan Cannabinoid properties of methylfluorophosphonate analogs Journal of Pharmacology and Experimental Therapeutics 294 3 2000 1209 1218
45. M.J. McFarland, and E.L. Barker Anandamide transport Pharmacology and Therapeutics 104 2 2004 117 135
46. M.J. McFarland, A.C. Porter, F.R. Rakhshan, D.S. Rawat, R.A. Gibbs, and E.L. Barker A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide Journal of Biological Chemistry 279 40 2004 41991 41997
47. G. Ortar, A. Ligresti, L. De Petrocellis, E. Morera, and V. Di Marzo Novel selective and metabolically stable inhibitors of anandamide cellular uptake Biochemical Pharmacology 65 9 2003 1473 1481
48. S. Ortega-Gutierrez, E.G. Hawkins, A. Viso, M.L. Lopez-Rodriguez, and B.F. Cravatt Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake Biochemistry 43 25 2004 8184 8190
49. M.P. Patricelli, and B.F. Cravatt Proteins regulating the biosynthesis and inactivation of neuromodulatory fatty acid amides Vitamins and Hormones 62 2001 95 131
50. D. Piomelli, M. Beltramo, S. Glasnapp, S.Y. Lin, A. Goutopoulos, X.Q. Xie, and A. Makriyannis Structural determinants for recognition and translocation by the anandamide transporter Proceedings of the National Academy of Sciences of the United States of America 96 10 1999 5802 5807
51. L. Ruiz-Llorente, S. Ortega-Gutierrez, A. Viso, M.G. Sanchez, A.M. Sanchez, C. Fernandez, J.A. Ramos, C. Hillard, M.A. Lasuncion, M.L. Lopez-Rodriguez, and I. Diaz-Laviada Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study British Journal of Pharmacology 141 3 2004 457 467
52. A. Sandberg, and C.J. Fowler Measurement of saturable and nonsaturable components of anandamide uptake into P19 embryonic carcinoma cells in the presence of fatty acid-free bovine serum albumin Chemistry and Physics of Lipids 134 2 2005 131 139
53. M. van der Stelt, and V. Di Marzo The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders European Journal of Pharmacology 480 1-3 2003 133 150
54. J.L. Wiley, and B.R. Martin Cannabinoid pharmacological properties common to other centrally acting drugs European Journal of Pharmacology 471 3 2003 185 193
55. J.L. Wiley, M.A. Dewey, R.G. Jefferson, R.L. Winckler, D.T. Bridgen, K.A. Willoughby, and B.R. Martin Influence of phenylmethylsulfonyl fluoride on anandamide brain levels and pharmacological effects Life Science 67 13 2000 1573 1583
56. D. Zakim Thermodynamics of fatty acid transfer Journal of Membrane Biology 176 2 2000 101 109
57. F. Zhang, F. Kamp, and J.A. Hamilton Dissociation of long and very long chain fatty acids from phospholipid bilayers Biochemistry 35 50 1996 16055 16060